Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-070630
Filing Date
2021-12-20
Accepted
2021-12-20 18:00:22
Documents
2
Period of Report
2021-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9902
2 POA DOCUMENT poa.txt EX-24 2047
  Complete submission text file 0001209191-21-070630.txt   13370
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
Schneyer Mark C. (Reporting) CIK: 0001899977 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 211506309